While these studies provided significant insight on how OTX2 contributes to MB growth, a more comprehensive understanding of OTX2‐mediated regulation in stem cell conditions will be critical, as cancer stem cells are major contributors to tumor initiation, recurrence, and poor prognosis in Group 3 and Group 4 MB patients. The gene discussed is OTX2; the disease is cancer.